2026-10-30 11:00:04 UTC#545087newconfirmednews
IDEXX Laboratories (IDXX) stock news
IDEXX Laboratories (IDXX) stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire20 wire items
2026-10-27 21:16:00 UTC#524407newconfirmednews
UBS maintains IDEXX Labs at Neutral, cuts price target to $627 from $670
2026-10-12 11:28:00 UTC#446223newconfirmednews
KeyBanc initiates IDEXX Laboratories at Sector Weight
2026-09-16 11:30:20 UTC#320288duplicateconfirmednews
IDEXX Laboratories acquires veterinary AI software provider CoVetAI
2026-09-16 11:00:00 UTC#320096newconfirmednews
IDEXX Laboratories acquires CoVetAI to integrate artificial intelligence into veterinary workflows
2026-09-14 15:41:52 UTC#308508newconfirmedanalysis
IDEXX Laboratories (IDXX) Q2 results show recurring revenue growth and margin expansion from diagnostic adoption
2026-09-14 15:39:38 UTC#308528duplicateconfirmednews
IDEXX Laboratories (IDXX) Q2 Results and Guidance Update Driven by Diagnostic Product Adoption
2026-08-13 22:12:49 UTC#174946updateconfirmedanalysis
IDEXX Laboratories growth strategy centers on diagnostic innovation and global expansion
2026-08-13 18:50:33 UTC#173760newconfirmedanalysis
IDEXX Laboratories (IDXX) targets 8.5%-11% recurring revenue growth and >32% operating margins
2026-08-11 14:01:00 UTC#159222newconfirmednews
Barclays maintains Overweight rating on IDEXX Laboratories (IDXX)
2026-08-11 11:02:08 UTC#158160newconfirmedpress release
IDEXX Laboratories Launches Catalyst proBNP Test for Cardiac Assessment in Cats and Dogs
2026-08-05 19:08:00 UTC#132082newconfirmednews
Citigroup maintains Neutral rating on IDEXX Laboratories
2026-08-04 19:20:06 UTC#125094newconfirmednews
IDEXX Laboratories average analyst price target raised to $719, implying 27% upside
2026-08-04 16:41:09 UTC#124541duplicateconfirmednews
IDEXX Laboratories reiterates 2026 revenue guidance of $4.70B-$4.75B and 5,500 inVue Dx unit placement target
seekingalpha.comimportance 0.30trust 0.80IDEXX Laboratories, Inc. +0.40Andrew Emerson 0Michael Erickson 0
2026-08-04 16:41:09 UTC#124518updateconfirmednews
IDEXX Laboratories targets $4.70B-$4.75B 2026 revenue and 5,500 inVue Dx placements
2026-08-04 13:31:41 UTC#123482duplicateconfirmednews
IDEXX Laboratories Q2 adjusted EPS $4.27 beats $3.94 estimate, revenue $1.22B beats $1.20B
2026-08-04 10:46:59 UTC#122222duplicateconfirmednews
IDEXX Laboratories Q2 revenue up 10%, EPS up 18%; FY26 guidance raised on diagnostics growth
2026-08-04 10:38:07 UTC#122154newconfirmednews
IDEXX Laboratories beats Q2 top and bottom-line estimates, updates FY26 outlook
2026-08-03 16:29:53 UTC#117991newconfirmednews
IDEXX Laboratories Q2 2026 Earnings Preview
2026-07-29 11:21:33 UTC#93584newconfirmednews